Impel Pharmaceuticals
Latest round
- Series D
Last raised
- Dec 2018
Total raised
- $91M
Investors
- 6
About Impel Pharmaceuticals
Founded in 2008 in Seattle, US, Impel NeuroPharma is dedicated to revolutionizing drug delivery through its proprietary technology.Impel Pharmaceuticals specializes in innovative intranasal drug delivery solutions, notably its flagship product, Trudhesa® (dihydroergotamine mesylate) nasal spray, which is approved for the acute treatment of migraines in adults. Utilizing Precision Olfactory Delivery (POD®) technology, Trudhesa® enhances drug absorption via the upper nasal space, promising rapid and consistent bioavailability. The company aims to expand its geographic reach, particularly targeting additional European markets by the end of 2024, while continuing to innovate within the intranasal drug delivery sector.
Who invested in Impel Pharmaceuticals
6 investors across 3 rounds
See all investors in Impel Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Impel Pharmaceuticals
Who invested in Impel Pharmaceuticals?
Impel Pharmaceuticals has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Impel Pharmaceuticals raised?
Impel Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Impel Pharmaceuticals last raise money?
Impel Pharmaceuticals's most recent round on record is a Series D, in Dec 2018.
What does Impel Pharmaceuticals do?
Founded in 2008 in Seattle, US, Impel NeuroPharma is dedicated to revolutionizing drug delivery through its proprietary technology.
Where is Impel Pharmaceuticals headquartered?
Impel Pharmaceuticals is headquartered in Seattle, US.
Which VCs invest in companies like Impel Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Impel Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Impel Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.